Amendment — tracked changes. This document shows UCI’s amendments as tracked changes: struck-through text is being removed and the adjacent plain text is its replacement. Some character-level edits (numbers, word fragments) from the source PDF may display imperfectly — for the clean, in-force wording see the consolidated regulation in the sidebar or the official PDF.

MEMORANDUM

UCI TESTING AND INVESTIGATIONS REGULATIONS (“UCI TIR”) Rules amendments applying on 5.06.2026

ANNEX D - COLLECTION OF VENOUS BLOOD SAMPLES

D.3 Responsibility

  • D.3.1 The DCO has the responsibility for ensuring that:

  • a) Each Sample is properly collected, identified and sealed; and

  • b) All Samples have been properly stored and dispatched in accordance with the relevant analytical guidelines; and

  • c) If a blood Sample is to be collected in a serum tube from the Rider, Sample collection shall not occur within sixty (60) minutes of the Rider’s training, participation in Competition or other similar physical activity. If the Rider has trained or competed less than sixty (60) minutes before the time the Rider has been notified of their selection, the DCO or other designated Sample Collection Personnel shall keep the Rider under direct observation until this 60-minute period has elapsed. The same applies for whole blood Samples analyzed for the Hematological Module of the Athlete Biological Passport in line with Annex I.2.1 and I.2.2. The DCO shall document on the Blood Collection Supplementary Report Form whether the Rider was engaged in any type of physical activity prior to Sample collection and if so record that the Rider waited the required sixty (60) minutes prior to Sample collection. This information shall be made available to the Laboratory.

[Comment to Annex D.3.1 c): Part of the sixty (60) minute wait includes the Rider sitting in an upright stationary position with their feet on the floor for at least ten (10) minutes as outlined in Article D.4.5. The sixty (60) minute wait does not apply to whole blood Samples collected in EDTA tubes that will not be analyzed for the Hematological Module of the Athlete Biological Passport.]

ANNEX I - COLLECTION, STORAGE AND TRANSPORT OF BLOOD ATHLETE BIOLOGICAL PASSPORT SAMPLES

I.2 Requirements

  • I.2.I Planning shall consider the Rider’s whereabouts information to ensure Sample collection does not occur within two sixty ( 26 0) hours minutes of the Rider’s training, participation in Competition or other similar physical activity. If the Rider has trained or competed less than two sixty ( 26 0) hours minutes before the time the Rider has been notified of their selection, the DCO or other designated Sample Collection Personnel shall chaperone the Rider until this two hours 60 minutes period has

elapsed.

  • I2.2 If the Sample was collected within two sixty (2 60) hours minutes of training or Competition, the nature, duration and intensity of the exertion shall be recorded by the DCO to make this information available to the APMU.

  • I2.9 The DCO / BCO shall collect and record the following additional information on a n Blood Collection Supplementary Report Form Athlete Biological Passport supplementary form, Athlete Biological Passport specific Doping Control form or other related report form to be signed by the Rider and the DCO/BCO:

  • a) Has the Rider been seated for at least ten (10) minutes with their feet on the floor prior to blood collection, as per Annex I.2.8?

  • b) Was the Sample collected immediately following at least three (3) consecutive days of an intensive endurance Competition, such as a stage race in cycling?

  • c) Will the Rider be competing within the next three (3) days (including today)?

  • c)d ) Has the Rider had a training session or Competition in the two sixty ( 26 0) hours minutes prior to the blood collection?

  • d)e ) Did the Rider train, compete or reside at an altitude greater than 1,500 meters within the prior two four ( 42 ) weeks? If so, or if in doubt, the name and location of the place where the Rider was previously located shall be recorded. The estimated altitude shall be entered, if known.

  • e)f ) Did the Rider use any form of altitude simulation such as a hypoxic tent, mask, etc. during the prior two four ( 42) weeks? If so, as much information as possible on the type of device and the manner and frequency of its use shall be recorded.

  • f)g ) Did the Rider receive any blood transfusion(s) during the prior three (3) months? Was there any blood loss due to accident, pathology or donation in the prior three (3) months? If so, the estimated volume should be recorded.

  • g)h ) Has the Rider been exposed to any extreme environmental conditions during the last two sixty (6 02) minutes hours prior to blood collection, including any sessions in any artificial heat environment such as a sauna? If so, the details should be recorded.

I.3 The Sample Collection Procedure

  • I.3.2 The Rider and the DCO/BCO sign the Doping Control and Blood Collection Athlete Biological Passport Ssu pplementary Report Ffo rm(s), when applicable.

I.4 Transportation Requirements

  • I4.6 The Testing Authority or Sample Collection Authority shall report without delay into ADAM:

  • a) The Doping Control form, as per Article 4.9.1 b);

  • b) The Blood Collection Supplementary Report Form Athlete Biological Passport supplementary form, and/or the additional information specific to the Athlete Biological Passport collected on a related report form;

  • c) In the Chain of Custody, the temperature data logger ID (without any time reference) and the time zone of the Testing location in GMT.